Article ; Online: Identifying molecular insight of synergistic complexities for SARS-CoV-2 infection with pre-existing type 2 diabetes.
Computers in biology and medicine
2021 Volume 136, Page(s) 104668
Abstract: ... the genetic factors and processes contributing to the synergistic severity of SARS-CoV-2 infection among T2D ... public health, especially to people with underlying health conditions. Type 2 diabetes (T2D) is lethal ... The ongoing COVID-19 outbreak, caused by SARS-CoV-2, has posed a massive threat to global ...
Abstract | The ongoing COVID-19 outbreak, caused by SARS-CoV-2, has posed a massive threat to global public health, especially to people with underlying health conditions. Type 2 diabetes (T2D) is lethal comorbidity of COVID-19. However, its pathogenetic link remains unclear. This research aims to determine the genetic factors and processes contributing to the synergistic severity of SARS-CoV-2 infection among T2D patients through bioinformatics approaches. We analyzed two sets of transcriptomic data of SARS-CoV-2 infection obtained from lung epithelium cells and PBMCs, and two sets of T2D data from pancreatic islet cells and PBMCs to identify the associated differentially expressed genes (DEGs) followed by their functional enrichment analyses in terms of protein-protein interaction (PPI) to detect hub-proteins and associated comorbidities, transcription factors (TFs), microRNAs (miRNAs) as well as the potential drug candidates. In PPI analysis, four potential hub-proteins (i.e., BIRC3, C3, MME, and IL1B) were identified among 25 DEGs shared between the disease pair. Enrichment analyses using the mutually overlapped DEGs revealed the most prevalent GO and cell signalling pathways, including TNF signalling, cytokine-cytokine receptor interaction, and IL-17 signalling, which are related to cytokine activities. Furthermore, as significant TFs, we identified IRF1, KLF11, FOSL1, and CREB3L1 while miRNAs including miR-1-3p, 34a-5p, 16-5p, 155-5p, 20a-5p, and let-7b-5p were found to be noteworthy. The findings illustrated the significant association between COVID-19 and T2D at the molecular level. These genetic determinants can further be explored for their specific roles in disease progression and therapeutic intervention, while significant pathways can also be studied as molecular checkpoints. Finally, the identified drug candidates may be evaluated for their potency to minimize the severity of COVID-19 patients with pre-existing T2D. |
|||||
---|---|---|---|---|---|---|
MeSH term(s) | COVID-19 ; Computational Biology ; Diabetes Mellitus, Type 2/genetics ; Humans ; MicroRNAs/genetics ; SARS-CoV-2 | |||||
Chemical Substances | MicroRNAs | |||||
Language | English | |||||
Publishing date | 2021-07-23 | |||||
Publishing country | United States | |||||
Document type | Journal Article | |||||
ZDB-ID | 127557-4 | |||||
ISSN | 1879-0534 ; 0010-4825 | |||||
ISSN (online) | 1879-0534 | |||||
ISSN | 0010-4825 | |||||
DOI | 10.1016/j.compbiomed.2021.104668 | |||||
Shelf mark |
|
|||||
Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 653: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.